Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model.

MLA

Ferrer-Lores, Blanca, et al. “Predicting Survival, Neurotoxicity and Response in B-Cell Lymphoma Patients Treated with CAR-T Therapy Using an Imaging Features-Based Model.” EJNMMI Research, vol. 14, no. 1, Nov. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s13550-024-01172-9.

APA

Ferrer-Lores, B., Ortiz-Algarra, A., Picó-Peris, A., Estepa-Fernández, A., Bellvís-Bataller, F., Weiss, G. J., Fuster-Matanzo, A., Fernández, J. P., Jimenez-Pastor, A., Hernani, R., Saus-Carreres, A., Benzaquen, A., Ventura, L., Piñana, J. L., Teruel, A. B., Serrano-Alcalá, A., Dosdá, R., Sopena-Novales, P., Balaguer-Rosello, A., & Guerreiro, M. (2024). Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model. EJNMMI Research, 14(1), 1–14. https://doi.org/10.1186/s13550-024-01172-9

Chicago

Ferrer-Lores, Blanca, Alfonso Ortiz-Algarra, Alfonso Picó-Peris, Alejandra Estepa-Fernández, Fuensanta Bellvís-Bataller, Glen J. Weiss, Almudena Fuster-Matanzo, et al. 2024. “Predicting Survival, Neurotoxicity and Response in B-Cell Lymphoma Patients Treated with CAR-T Therapy Using an Imaging Features-Based Model.” EJNMMI Research 14 (1): 1–14. doi:10.1186/s13550-024-01172-9.